MELACINI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 5.265
EU - Europa 2.552
AS - Asia 828
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 8.661
Nazione #
US - Stati Uniti d'America 5.255
IT - Italia 1.611
CN - Cina 440
SG - Singapore 308
SE - Svezia 190
FI - Finlandia 178
UA - Ucraina 162
DE - Germania 157
FR - Francia 107
GB - Regno Unito 55
IN - India 30
VN - Vietnam 25
NL - Olanda 23
IE - Irlanda 11
CA - Canada 9
RU - Federazione Russa 8
BE - Belgio 7
ES - Italia 7
GR - Grecia 7
HK - Hong Kong 7
TR - Turchia 7
CH - Svizzera 6
AU - Australia 4
BR - Brasile 4
EU - Europa 4
PL - Polonia 4
AT - Austria 3
CZ - Repubblica Ceca 3
JP - Giappone 3
RO - Romania 3
ID - Indonesia 2
IL - Israele 2
IR - Iran 2
NO - Norvegia 2
RS - Serbia 2
AL - Albania 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
Totale 8.661
Città #
Chandler 607
Fairfield 605
Jacksonville 466
Woodbridge 340
Ann Arbor 315
Houston 313
Ashburn 307
Wilmington 259
Singapore 255
Seattle 221
Cambridge 203
Santa Clara 161
Boardman 149
Princeton 149
Beijing 127
Milan 126
Rome 121
Des Moines 83
Roxbury 79
Helsinki 77
Medford 76
San Diego 58
Florence 47
Nanjing 47
Padova 37
Munich 36
Guangzhou 26
Dong Ket 25
New York 25
Shenyang 25
Naples 23
Palermo 22
Redwood City 21
Changsha 20
Verona 19
Brescia 18
Norwalk 15
Turin 14
Dallas 13
Bari 12
Bologna 12
Jiaxing 12
Perugia 12
Dublin 11
Monza 11
Napoli 11
Nanchang 10
Trento 10
Pisa 9
Indiana 8
Livorno 8
Falls Church 7
Genoa 7
Hong Kong 7
Los Angeles 7
Paris 7
Tianjin 7
Zhengzhou 7
Bergamo 6
Cagliari 6
Hebei 6
Hefei 6
Jinan 6
London 6
Manchester 6
Mumbai 6
Carpi 5
Chicago 5
Hangzhou 5
Lucca 5
Ravenna 5
Rochester 5
Shanghai 5
Trieste 5
Udine 5
Borås 4
Boves 4
Bussolengo 4
Castellammare di Stabia 4
Menlo Park 4
Ningbo 4
Pescara 4
Rockville 4
Taranto 4
Treviso 4
Verdellino 4
Villa Carcina 4
Acton 3
Afragola 3
Andover 3
Ankara 3
Arezzo 3
Bisceglie 3
Bogogno 3
Brno 3
Brussels 3
Campogalliano 3
Cantù 3
Capua 3
Castel Maggiore 3
Totale 5.885
Nome #
Ruolo dell'NT-proBNP nella cardiomiopatia ipertrofica 762
Ruolo della risonanza magnetica cardiaca nella stratificazione prognostica dei pazienti con cardiomiopatia ipertrofica 629
Screening di mutazioni patogene nei quattro geni più frequentemente implicati nella cardiomiopatia ipertrofica 472
Ricerca di mutazioni patogene in pazienti affetti da cardiomiopatia ipertrofica: risultati dello screening genetico per 12 geni con tecnica di DNA resequencing array. 184
Cardioembolic stroke in Danon disease. 141
Clinicopathologicalprofiles of progressive heart failure in hypertrophic cardiomyopathy. 122
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 120
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 115
Digitalis and the renin-angiotensin axis in congestive heart failure. 108
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 107
Radial function correlates with heart failure symptoms in hypertrophic cardiomyopathy with normal ejection fraction 106
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 103
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations 98
Cardiac involvement in Becker muscular dystrophy 97
HYPERTROPHIC CARDIOMYOPATHY: TWO-DIMENSIONAL ECHOCARDIOGRAPHIC SCORE VERSUS CLINICAL AND ELECTROCARDIOGRAPHIC FINDINGS: 96
LGMD2E patients risk developing dilated cardiomyopathy 95
QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest 92
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. 89
Prognostic factors in mild dystrophinopathies. 89
Effects of phospholipase C on the electrical and mechanical activity of guinea pig taenia coli. 89
Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy 89
Risk of Arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 88
Cardiac Findings in Congenital Muscular Dystrophies. 88
Marginal Overlap between Electrocardiographic Abnormalities in patients with Hypertrophic Cardiomyopathy and Trained Athletes: Implications for Preparticipation Screening. 87
The natural history of cardiac involvement in myotonic dystrophy: an eight-year follow-up in 17 patients. 85
Long-term echocardiographic Doppler monitoring of Hancock bioprostheses in the aortic valve position. 85
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy 83
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. 82
Detection of Myocardial Fibrosis, Edema and Hypoperfusion in Hypertrophic Cardiomyopathy By Magnetic Resonance Imaging 81
Evolutionary persistence of spongy myocardium in humans. 81
Relationship of 3D left ventricular mass with systolic and diastolic function indices in hypertrophic cardiomyopathy 81
Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies 81
"Hot phase" nella cardiomiopatiaipertrofica?Ruolo delle troponine ad alta sensibilità. 79
A pharmacological approach to the study of AV conduction in man. 79
[Evaluation of clinical data and effort test in patients with angina pectoris: an approach to a multivariate analysis in different groups]. 79
Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia 77
Effect of digoxin on plasma-renin-activity in man. 76
Evolution of cardiac involvement in progressive ophthalmoplegia with deleted mitochondrial DNA. 76
Long-term echocardiographic evaluation of closed and open mitral valvulotomy. 75
Utilità della diagnostica non invasiva ed invasiva nella stratificazione del rischio aritmico ipo ed ipercinetico nella Distrofia Miotonica tipo I. 75
Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. 75
Multisystem primary defect of LAMP-2 in Danon disease 74
Three-dimensional myocardial strain patterns in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative study 74
Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I 73
Novel Missense Variant in MYL2 Gene Associated with Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology 73
123I-MIBG scintigraphic assessment of sympathetic innervation in hypertrophic cardiomyopathy patients with and without severe tachyarrhythmias 72
Multisystemic LAMP-2 defect in Danon disease. 71
Plasma levels of digoxin in patients with atrial fibrillation and indications to the association with beta blockers. 70
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies 70
Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice. 68
LONG-TERM ECHOCARDIOGRAPHIC DOPPLER MONITORING OF HANCOCK BIOPROSTHESES IN THE MITRAL-VALVE POSITION 68
Echocardiography 67
Cardiomyopathy in b-sarcoglycanopathies: a new pathogenetic hypothesis 67
CORRELATION BETWEEN CARDIAC INVOLVEMENT AND CTG TRINUCLEOTIDE REPEAT LENGTH IN MYOTONIC DYSTROPHY 67
Prevalence and echocardiographic features of a normal electrocardiogram in patients with hypertrophic cardiomyopathy: implications for pre-participation screening 67
Consensus statement on standard of care for congenital muscular dystrophies 66
Sympathetic myocardial innervation and prognosis in hypertrophic cardiomyopathy: aprospective , long-term study in a tertiary center. 64
Myocardial damage biomarkers in hypertrophic cardiomyopathy: prognostic role of high sensitivity cardiac troponin I and T. 64
Long-term results of mitral commissurotomy. 64
Cardiac transplantation in a Duchenne muscular dystrophy carrier 63
Relationship between 12-lead ECG and CTG expansion in myotonic dystrophy after 10 years of follow-up 62
[Effects of digoxin on plasma renin activity in man. II]. 62
ROLE OF "ISCHEMIA MODIFIED ALBUMIN" IN DETECTING MYOCARDIAL ISCHEMIA IN HYPERTROPHIC CARDIOMYOPATHY 62
Role of “Ischemia Modified Albumin” in detecting myocardial ischemia in hypertrophic cardiomyopathy. 61
The role of non-invasive methods in determining the arrhythmic risk in myotonic dystrophy type 1 59
DNA resequencing array for mutation detection in hypertrophic cardiomyopathy 57
Ecocardiografia 56
[Correlation between plasma concentration and therapeutic activity of digoxin in the treatment of atrial fibrillation and indications for the association of beta blockers]. 56
[Blood levels of digoxin and digitoxin during hemodialysis]. 55
[Quantitative echocardiographic study of the left ventricular function in acute aortic infective endocarditis]. 55
[Atypical response of the A-V node to continuous atrial stimulation: an electrophysiological interpretation]. 54
[The heart in myotonic dystrophy. Clinical and instrumental study in 17 patients (author's transl)]. 53
[Changes of the amplitude of the R wave and behavior of the ST tract during exercise test. Comparison with hemodynamic and coronarographic data]. 52
[Vagal hypertonicity in congenital AV block. Apropos of a case]. 52
Atrio-ventricular conduction system in myotonic dystrophy: value of electrophysiological investigation. 51
Characterisation of transmural longitudinal and circumferential mechanics by multi-layer strain analysis in hypertrophic cardiomyopathy 50
Diverse profiles and determinants of progressive heart failure and death in hypertrophic cardiomyopathy 49
Effects of quinidine and diphenylhydantoin on membrane resistance in smooth muscle. 48
[Effects of verapamil on the electrical and mechanical activity of smooth muscle]. 48
COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH 48
[Approach to the pharmacological study of the various structures of the A-V node]. 48
[Electrophysiological demonstration of more structures in the atrioventricular node (author's transl)]. 47
Myopathy with tubular aggregates and hypertrophic cardiomyopathy in a patient with type IIA von Willebrand disease. 46
[Contribution of electrovectorcardiography in the diagnosis of hypertrophic cardiomyopathy. Comparative study with an echocardiographic score]. 46
Beta-sarcoglycan gene mutations cause plasma membrane dysruption in striated and smooth muscle, leading to severe dilated cardiomyopathy 44
Myocardial involvement is very frequent among patients affected with subclinical muscular dystrophy 44
Diagnostic mutation analysis in hypertrophic cardiomyopathy by DNA resequencing array 43
Malattie del miocardio 42
Diagnosis and treatment of cardiac involvement in Becker muscular dystrophy 41
SPONTANEOUS AND VASODEPRESSORY VASOVAGAL SYNCOPE IN HYPERTROPHIC CARDIOMYOPATHY. 41
Left atrial longitudinal strain correlates better than its emptying fraction with left ventricular impairment in hypertrophic cardiomyopathy 41
Risk of arrhythmia in type 1 myotonic dystrophy: the role of clinical and genetic variables 40
Effects of digoxin on plasma renin activity in hypertensive patients. 40
Hypertrophic cardiomyopathy related deaths in an Italian tertiary center 39
[Diagnostic value of the exercise test and of hyperpnea in women suspected of ischemic cardiopathy]. 38
Screening of the four genes most commonly involved in hypertrophic cardiomyopathy. 37
Dilated cardiomyopathy due to mutations in the fukutin related protein gene 32
Cuore e malattie neuromuscolari 32
Cuore, malattie neuromuscolari e malattie del sistema nervoso 30
Malattie del miocardio 29
Totale 8.608
Categoria #
all - tutte 28.017
article - articoli 19.838
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.112
Totale 48.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020746 0 0 0 0 0 0 99 155 106 162 117 107
2020/20211.111 44 96 48 90 78 107 43 89 168 94 158 96
2021/20221.297 49 204 76 92 72 129 48 125 59 38 145 260
2022/20231.489 262 149 75 177 208 230 27 90 138 28 75 30
2023/2024919 31 118 101 70 78 93 46 70 48 72 82 110
2024/20251.089 55 229 151 149 362 127 16 0 0 0 0 0
Totale 8.700